147 related articles for article (PubMed ID: 30280921)
1. Effect of Testosterone Use on Bone Mineral Density in HIV-Infected Men.
Grant PM; Li X; Jacobson LP; Palella FJ; Kingsley LA; Margolick JB; Dobs AS; Lake JE; Althoff KN; Brown TT
AIDS Res Hum Retroviruses; 2019 Jan; 35(1):75-80. PubMed ID: 30280921
[TBL] [Abstract][Full Text] [Related]
2. CD4 T cell count is inversely associated with lumbar spine bone mass in HIV-infected men under the age of 50 years.
Kwak MK; Lee EJ; Park JW; Park SY; Kim B-; Kim TH; Suh K; Koh J-; Lee SH; Byun D-
Osteoporos Int; 2019 Jul; 30(7):1501-1510. PubMed ID: 30915506
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of monthly ibandronate in men with low bone density.
Orwoll ES; Binkley NC; Lewiecki EM; Gruntmanis U; Fries MA; Dasic G
Bone; 2010 Apr; 46(4):970-6. PubMed ID: 20060082
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density changes among people living with HIV who have started with TDF-containing regimen: A five-year prospective study.
Han WM; Wattanachanya L; Apornpong T; Jantrapakde J; Avihingsanon A; Kerr SJ; Teeratakulpisarn N; Jadwattanakul T; Chaiwatanarat T; Buranasupkajorn P; Ramautarsing R; Phanuphak N; Sunthornyothin S; Ruxrungtham K; Phanuphak P;
PLoS One; 2020; 15(3):e0230368. PubMed ID: 32210458
[TBL] [Abstract][Full Text] [Related]
5. Association of regional body composition with bone mineral density in HIV-infected and HIV-uninfected women: women's interagency HIV study.
Sharma A; Tian F; Yin MT; Keller MJ; Cohen M; Tien PC
J Acquir Immune Defic Syndr; 2012 Dec; 61(4):469-76. PubMed ID: 22895436
[TBL] [Abstract][Full Text] [Related]
6. Unravelling hip-spine bone mineral density discordance in people living with HIV.
Vizcarra P; Rosillo M; Del Rey JM; Moreno A; Vivancos MJ; Casado JL
J Bone Miner Metab; 2022 Nov; 40(6):990-997. PubMed ID: 36038672
[TBL] [Abstract][Full Text] [Related]
7. Determinants of bone density in healthy older men with low testosterone levels.
Kenny AM; Prestwood KM; Marcello KM; Raisz LG
J Gerontol A Biol Sci Med Sci; 2000 Sep; 55(9):M492-7. PubMed ID: 10995046
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal changes in bone mineral density and trabecular bone score in Korean adults: a community-based prospective study.
Park SY; Kim JH; Choi HJ; Ku EJ; Hong AR; Lee JH; Shin CS; Cho NH
Arch Osteoporos; 2020 Jul; 15(1):100. PubMed ID: 32621253
[TBL] [Abstract][Full Text] [Related]
9. Serum total estradiol, but not testosterone is associated with reduced bone mineral density (BMD) in HIV-infected men: a cross-sectional, observational study.
Santi D; Madeo B; Carli F; Zona S; Brigante G; Vescini F; Guaraldi G; Rochira V
Osteoporos Int; 2016 Mar; 27(3):1103-1114. PubMed ID: 26510848
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of reduced bone mineral density in primary HIV-1-infected men.
Grijsen ML; Vrouenraets SM; Steingrover R; Lips P; Reiss P; Wit FW; Prins JM
AIDS; 2010 Sep; 24(14):2233-8. PubMed ID: 20616695
[TBL] [Abstract][Full Text] [Related]
11. Effect of Testosterone Treatment on Volumetric Bone Density and Strength in Older Men With Low Testosterone: A Controlled Clinical Trial.
Snyder PJ; Kopperdahl DL; Stephens-Shields AJ; Ellenberg SS; Cauley JA; Ensrud KE; Lewis CE; Barrett-Connor E; Schwartz AV; Lee DC; Bhasin S; Cunningham GR; Gill TM; Matsumoto AM; Swerdloff RS; Basaria S; Diem SJ; Wang C; Hou X; Cifelli D; Dougar D; Zeldow B; Bauer DC; Keaveny TM
JAMA Intern Med; 2017 Apr; 177(4):471-479. PubMed ID: 28241231
[TBL] [Abstract][Full Text] [Related]
12. Quantitative bone SPECT in young males with delayed puberty and hypogonadism: implications for treatment of low bone mineral density.
Lubushitzky R; Front D; Iosilevsky G; Bettman L; Frenkel A; Kolodny GM; Israel O
J Nucl Med; 1998 Jan; 39(1):104-7. PubMed ID: 9443746
[TBL] [Abstract][Full Text] [Related]
13. A Comparison of Bone Mineral Density and Its Predictors in HIV-Infected and HIV-Uninfected Older Men.
Nimitphong H; Sungkanuparph S; Saetung S; Chailurkit LO; Sritara C; Musikarat S; Ongphiphadhanakul B
Endocr Pract; 2021 Dec; 27(12):1225-1231. PubMed ID: 34343711
[TBL] [Abstract][Full Text] [Related]
14. Brief Report: Association of Adipokines With Bone Mineral Density in HIV-Infected and HIV-Uninfected Women.
Sharma A; Ma Y; Scherzer R; Wheeler AL; Cohen M; Gustafson DR; Keating SM; Yin MT; Tien PC
J Acquir Immune Defic Syndr; 2016 Dec; 73(4):433-437. PubMed ID: 27792683
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in bone loss and relation to menopause among HIV-infected and uninfected women.
Sharma A; Flom PL; Rosen CJ; Schoenbaum EE
Bone; 2015 Aug; 77():24-30. PubMed ID: 25896953
[TBL] [Abstract][Full Text] [Related]
16. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV.
McComsey GA; Kendall MA; Tebas P; Swindells S; Hogg E; Alston-Smith B; Suckow C; Gopalakrishnan G; Benson C; Wohl DA
AIDS; 2007 Nov; 21(18):2473-82. PubMed ID: 18025884
[TBL] [Abstract][Full Text] [Related]
17. Nonstandard Lumbar Region in Predicting Fracture Risk.
Alajlouni D; Bliuc D; Tran T; Pocock N; Nguyen TV; Eisman JA; Center JR
J Clin Densitom; 2018; 21(2):220-226. PubMed ID: 28689879
[TBL] [Abstract][Full Text] [Related]
18. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of bone mineral density changes in aging men with or at risk for HIV infection.
Sharma A; Flom PL; Weedon J; Klein RS
AIDS; 2010 Sep; 24(15):2337-45. PubMed ID: 20683316
[TBL] [Abstract][Full Text] [Related]
20. Quantitative ultrasound and dual-energy X-ray absorptiometry in the prediction of fragility fracture in men.
Gonnelli S; Cepollaro C; Gennari L; Montagnani A; Caffarelli C; Merlotti D; Rossi S; Cadirni A; Nuti R
Osteoporos Int; 2005 Aug; 16(8):963-8. PubMed ID: 15599495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
